SARC 028: A phase II study of the anti-PD1 antibody pembrolizumab (P) in patients (Pts) with advanced sarcomas.

Published

Conference Paper

Full Text

Duke Authors

Cited Authors

  • Burgess, MA; Crowley, J; Reinke, DK; Riedel, RF; George, S; Movva, S; Van Tine, BA; Davis, LE; Schuetze, S; Hu, J; Attia, S; Priebat, DA; Reed, DR; D'Angelo, SP; Okuno, SH; Maki, RG; Patel, S; Baker, LH; Tawbi, HA-H

Published Date

  • May 20, 2015

Published In

Volume / Issue

  • 33 / 15

Published By

Pages

  • 1

Electronic International Standard Serial Number (EISSN)

  • 1527-7755

International Standard Serial Number (ISSN)

  • 0732-183X

Conference Name

  • Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO) / Clinical Science Symposium on Predicting and Improving Adverse Outcomes in Older Adults with Cancer

Conference Location

  • Chicago, IL

Conference Start Date

  • May 29, 2015

Conference End Date

  • June 2, 2015